Evidence map›Paper›PMID 14986770›Full record

ReviewScience and engineering ethics2004

The use of the placebo effect in clinical medicine--ethical blunder or ethical imperative?

Nikola Biller-Andorno

Abstract readReview
PubMed Publisher
In one paragraph

Review in Science and engineering ethics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Perception and practice of placebo use among physicians in Mangalore.Journal of family medicine and primary care · 2020
    Article
  7. Article
  8. Article
  9. Placebo interventions in practice: a questionnaire survey on the attitudes of patients and physicians.The British journal of general practice : the journal of the Royal College of General Practitioners · 2011
    Article
  10. Article
  11. What is the place for placebo in the management of psychogenic disease?Journal of the Royal Society of Medicine · 2007
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Nikola Biller-AndornoDepartment of Medical Ethics and History of Medicine, University of Goettingen, Germany. nbiller@gwdg.de

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current debate in medical ethics on placebos focuses mainly on their use in health research. Whereas this is certainly an important topic the discussion tends to overlook another longstanding but nevertheless highly relevant question, namely if and how the placebo effect should be employed in clinical practice. This paper describes the way the placebo effect is perceived in modern medicine and offers some historical reflections on how these perceptions have developed; discusses elements of a definition of the placebo effect; and suggests some conditions under which making use of the therapeutic potential of the placebo effect can be ethically acceptable, if not warranted.

Indexed as

Ethics, ClinicalPhysician-Patient RelationsPlacebo EffectAttitude to HealthHuman ExperimentationHumansPlacebosPlacebosHealth Care and Public Health

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.